CF
AEON.WS

Cantor Fitzgerald’s AEON Biopharma Inc AEON.WS Stock Holding History

Cantor Fitzgerald’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-596,666
Closed -$59.6K – 350
2023
Q4 		$59.6K Hold
596,666
– – 0.01% 165
2023
Q3 		$89.5K Hold
596,666
– – ﹤0.01% 463
2023
Q2 		$53.7K Hold
596,666
– – ﹤0.01% 499
2023
Q1 		$32.8K Hold
596,666
– – ﹤0.01% 592
2022
Q4 		$27K Hold
596,666
– – ﹤0.01% 633
2022
Q3 		$42K Hold
596,666
– – ﹤0.01% 661
2022
Q2 		$90K Buy
596,666
+466,666
+359% +$98.1K ﹤0.01% 686
2022
Q1 		$39K Buy
130,000
+53,259
+69% +$22K ﹤0.01% 342
2021
Q4 		$39K Buy
+76,741
New +$42.4K ﹤0.01% 356

Other funds holding AEON.WS

DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Cantor Fitzgerald's AEON.WS Position: Q1 2024 in Review

Cantor Fitzgerald sold out of AEON Biopharma Inc (AEON.WS) in Q1 2024, closing a stake of 596,666 shares — an estimated $59.6K sold.

Cantor Fitzgerald first reported a position in AEON.WS in Q4 2021 and held it in 9 quarters. The position peaked at $90K in Q2 2022. 30 funds tracked by Wall St. Rank hold AEON.WS as of Q1 2024.

  • Cantor Fitzgerald reported no remaining AEON Biopharma Inc position as of Q1 2024 after selling out during the quarter.
  • Cantor Fitzgerald sold 596,666 AEON Biopharma Inc shares in Q1 2024, an estimated $59.6K.
  • Cantor Fitzgerald first reported a position in AEON Biopharma Inc in Q4 2021 and held it in 9 quarters.
  • Cantor Fitzgerald's AEON Biopharma Inc position peaked at $90K in Q2 2022.
  • 30 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q1 2024.

Based on Cantor Fitzgerald's 13F filing for Q1 2024, filed 15 May 2024.